My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 2 results for

GO
Search Filters: Maine cancel Population Health and Prevention cancel Michigan cancel Pennsylvania cancel Vermont cancel New Hampshire cancel Maryland cancel Ohio cancel

Updated Rundown of State and Territorial COVID-19 Mask Requirements

Blog,
Health Policy Update,
Infectious Disease,
COVID-19,
COVID and Community Mitigation,
COVID and Law/Policy,
Policy,
State Health Policy,
Territorial Health Policy,
Federal Government Affairs,
Public Health Law,
Preparedness,
Pandemics,
Population Health and Prevention,
Women, Infant, and Family Health,
Alabama,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Washington, D.C.,
Guam,
Hawaii,
Illinois,
Indiana,
Kansas,
Kentucky,
Louisiana,
Maine,
Maryland,
Massachusetts,
Michigan,
Minnesota,
Mississippi,
Montana,
Nevada,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Carolina,
Ohio,
Oregon,
Pennsylvania,
Puerto Rico,
Rhode Island,
Texas,
Vermont,
Virgin Islands,
Virginia,
Washington,
West Virginia,
Wisconsin,
Andy Baker-White

Several states and territories, as well as many local governments, are going beyond recommendations and requiring individuals to wear face coverings when they are in public settings and spaces (i.e. grocery stores, retail stores, ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...